S. K. Tat

发表

Diacerein inhibits the synthesis of resorptive enzymes and reduces osteoclastic differentiation/survival in osteoarthritic subchondral bone: a possible mechanism for a protective effect against subchondral bone remodelling

J. Pelletier, J. Martel-Pelletier, C. Boileau, 2008, Arthritis research & therapy.

OPG/membranous--RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradation.

M. Padrines, S. Théoleyre, D. Heymann, 2006, Bone.

Variable Effects of 3 Different Chondroitin Sulfate Compounds on Human Osteoarthritic Cartilage/Chondrocytes: Relevance of Purity and Production Process

J. Pelletier, J. Martel-Pelletier, F. Mineau, 2010, The Journal of Rheumatology.

New perspective in osteoarthritis: the OPG and RANKL system as a potential therapeutic target?

J. Pelletier, J. Martel-Pelletier, M. Padrines, 2009, The Keio journal of medicine.

Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts.

J. Pelletier, J. Martel-Pelletier, F. Mineau, 2011, Bone.

Differential modulation of RANKL isoforms by human osteoarthritic subchondral bone osteoblasts: influence of osteotropic factors.

J. Pelletier, J. Martel-Pelletier, H. Fahmi, 2008, Bone.

Proteinase-activated receptor (PAR)-2 activation impacts bone resorptive properties of human osteoarthritic subchondral bone osteoblasts.

J. Pelletier, J. Martel-Pelletier, D. Lajeunesse, 2009, Bone.

The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling.

S. Théoleyre, D. Heymann, Y. Fortun, 2004, Cytokine & growth factor reviews.

Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study

J. Pelletier, J. Martel-Pelletier, H. Fahmi, 2007, Arthritis research & therapy.

Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: Role in the interactions with receptor activator of nuclear factor κB ligand (RANKL) and RANK

Frédéric Blanchard, John T. Gallagher, S. Ricard-Blum, 2006 .

Influence of Tumor Necrosis Factor α, Parathyroid Hormone, and Vitamin D3 on Modulation of the RANKL2 Isoform

J. Pelletier, J. Martel-Pelletier, M. Padrines, 2012, Cartilage.

Effects of chondroitin sulfate in the pathophysiology of the osteoarthritic joint: a narrative review.

J. Martel-Pelletier, J. Pelletier, S. Kwan Tat, 2010, Osteoarthritis and cartilage.

The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.

J. Pelletier, J. Martel-Pelletier, H. Fahmi, 2008, Clinical and experimental rheumatology.

Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts.

J. Pelletier, J. Martel-Pelletier, F. Mineau, 2011, Bone.